Good morning, everyone, and nice to see you again. A sunny day is unfolding here on the Pharmalot corporate campus, where we are brewing our mandatory cup of stimulation. This looks to be a busy day filled with meetings and deadlines. We know you can relate. So grab your own cup of something and dig in to read the news of the world. Remember to stop back as we update this post each morning. Have a good one and do stay in touch...
Vaginal Gel Reduces Premature Births In Some Women (Associated Press)
Novartis Gilenya MS Pill To Cost $34K In Germany (Bloomberg News)
HPV Might Be Linked To Lung Cancer (Health Day)
Cephalon Board Rejects $7.5B Valent Offer As Too Low (Bloomberg News)
Supreme Court Block Texas From Using Pentobarb For Execution (Associated Press)
FDA Issues Guidance On Cross-Contamination Prevention (InPharma Technologist)
Japanese Drugmakers In US Face Radiation Challenge (The Star-Ledger)